Skip to main content
. Author manuscript; available in PMC: 2024 Dec 2.
Published in final edited form as: Ann Rheum Dis. 2023 May 2;82(8):1091–1097. doi: 10.1136/ard-2023-223873

Figure 1.

Figure 1.

The most differentially overexpressed genes in anti-Mi2 dermatomyositis muscle compared to all the other muscle biopsies included in the study (histologically normal muscle biopsies [NT], non-anti-Mi2 dermatomyositis [DM], antisynthetase syndrome [AS], immune-mediated necrotizing myositis [IMNM], and inclusion body myositis [IBM]).